ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia

University Health Network, Toronto · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
chronic phase chronic myeloid leukemia, accelerated phase chronic myeloid leukemia, blastic phase chronic myeloid leukemia, philadelphia positive acute lymphoblastic leukemia, resistant to tyrosine kinase inhibitor therapy, tyrosine kinase inhibitor resistance, chronic myeloid leukemia, acute lymphoblastic leukemia, nilotinib, ruxolitinib, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 842550
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.